Peter Kolchinsky, Director: Climb Bio CLYM Buy · Filed 24/07/01

Trade details

Type: Insider buy
Amount: $45,884,816.64
Shares · price: 11,949,171 sh · $3.84 a share
Held after: 23,521,757 sh
Stock: Climb Bio CLYM
Person: Peter KolchinskyDirector
Trade date: 24/06/27
Filed: 24/07/01
Days to filing: 4 days

First buy since 2023

Insiders buying this week: 7 insiders
Holding change: +103.3%

Climb Bio trades, last 26 weeks

What else happened in Climb Bio around then

Filed or reported within 30 days of the trade day · 24/05/28~24/07/27

Peter Kolchinsky's recent trades

Peter KolchinskyDirector
BuyArtiva Biotherapeutics
Buy
Artiva Biotherapeutics
ARTV
$275.3K
31,000 sh
$275.3K
Filed 06/29
Traded 06/25
Peter KolchinskyDirector
BuyArtiva Biotherapeutics
Buy
Artiva Biotherapeutics
ARTV
$16.8K
1,876 sh
$16.8K
Filed 06/29
Traded 06/26
Peter Kolchinsky10% Owner
SellWerewolf Therapeutics
Sell
Werewolf Therapeutics
HOWL
$136.2K
389,216 sh
$136.2K
Filed 06/22
Traded 06/17
Peter Kolchinsky10% Owner
SellWerewolf Therapeutics
Sell
Werewolf Therapeutics
HOWL
$9,693
27,695 sh
$9,693
Filed 06/22
Traded 06/17
Peter Kolchinsky10% Owner
BuyHemab Therapeutics Holdings
Buy
Hemab Therapeutics Holdings
COAG
$1.5M
61,523 sh
$1.5M
Filed 06/17
Traded 06/16

Peter Kolchinsky, Director — bought $45.9M of Climb Bio CLYM · 11,949,171 sh @ $3.84 | Whalegun